✦ LIBER ✦

Equivalence of dirac and intrinsic quantization for non-free group actions

✍ Scribed by C. Emmrich

Publisher: Springer
Year: 1993
Tongue: English
Weight: 674 KB
Volume: 151
Category: Article
ISSN: 0010-3616
DOI: 10.1007/bf02097026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cocycle and orbit equivalence superrigid

Cocycle and orbit equivalence superrigidity for malleable actions of w-rigid groups

✍ Sorin Popa 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 693 KB

Elementary equivalence for the lattices

Elementary equivalence for the lattices of subalgebras and automorphism groups of free algebras

✍ A. G. Pinus 📂 Article 📅 2008 🏛 SP MAIK Nauka/Interperiodica 🌐 English ⚖ 117 KB

Factors affecting stability and equilibr

Factors affecting stability and equilibria of free radicals—IX: Non-equivalence of aryl groups in 1,1-diaryl-2-benzenesulphonyl-hydrazyls and related compounds

✍ A.T. Balaban; M.T. Cǎproiu; N. Negoiţǎ; R. Baican 📂 Article 📅 1977 🏛 Elsevier Science 🌐 French ⚖ 430 KB

Non-perturbative renormalization of vect

Non-perturbative renormalization of vector and axial vector currents in quenched QCD for a renormalization group improved gauge action

✍ K. Ide; S. Aoki; M. Fukugita; N. Ishizuka; Y. Iwasaki; K. Kanaya; T. Kaneko; Y. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 269 KB

Renormalization constants of vector (2,) and axial-vector (ZA) currents are determined non-perturbatively in quenched QCD for an RG-improved gauge action and a tadpole-improved clover quark action using the Schr6dinger functional method. Meson decay constants f, and fT show much better scaling when

A VM 26-based regimen for patients with

A VM 26-based regimen for patients with previously untreated non-Hodgkin lymphoma. Prolonged disease-free survival in patients younger than 60 years of age: A phase II trial of the eastern cooperative oncology group

✍ Leo I. Gordon; Janet Andersen; Stephanie Gregory; Joseph Mazza; Paul Chervenick; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 545 KB

Background. The epidophyllotoxin VM 26 has been shown to have single-agent activity in patients with diffuse aggressive lymphoma. In an attempt to determine its activity in combination with other agents known to be effective in lymphoma, a Phase I1 trial of a novel chemotherapy regimen was conducted